These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24700436)

  • 1. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
    Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
    Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Liver Injury from Statins.
    Meurer L; Cohen SM
    Clin Liver Dis; 2020 Feb; 24(1):107-119. PubMed ID: 31753243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
    Siramolpiwat S; Sakonlaya D
    Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury associated with statins.
    Russo MW; Scobey M; Bonkovsky HL
    Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series.
    Heidemann LA; Navarro VJ; Ahmad J; Hayashi PH; Stolz A; Kleiner DE; Fontana RJ
    Dig Dis Sci; 2016 Sep; 61(9):2741-8. PubMed ID: 27142670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry.
    Perdices EV; Medina-Cáliz I; Hernando S; Ortega A; Martín-Ocaña F; Navarro JM; Peláez G; Castiella A; Hallal H; Romero-Gómez M; González-Jiménez A; Robles-Díaz M; Lucena MI; Andrade RJ
    Rev Esp Enferm Dig; 2014 Apr; 106(4):246-54. PubMed ID: 25075655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
    Björnsson ES; Gu J; Kleiner DE; Chalasani N; Hayashi PH; Hoofnagle JH;
    J Clin Gastroenterol; 2017 Jan; 51(1):63-69. PubMed ID: 27648552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
    Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
    Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and histopathologic features of fluoroquinolone-induced liver injury.
    Orman ES; Conjeevaram HS; Vuppalanchi R; Freston JW; Rochon J; Kleiner DE; Hayashi PH;
    Clin Gastroenterol Hepatol; 2011 Jun; 9(6):517-523.e3. PubMed ID: 21356330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Kwo PY; Cohen SM; Lim JK
    Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
    Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amoxicillin-Clavulanate-Induced Liver Injury.
    deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
    Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia.
    Desai NK; Mendelson MM; Baker A; Ryan HH; Griggs S; Boghani M; Yellen E; Buckley L; Gillman MW; Zachariah JP; Graham D; Jonas MM; de Ferranti SD
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):175-181. PubMed ID: 30334928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
    Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
    J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
    Tsung I; Dolan R; Lao CD; Fecher L; Riggenbach K; Yeboah-Korang A; Fontana RJ
    Aliment Pharmacol Ther; 2019 Oct; 50(7):800-808. PubMed ID: 31309615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    Björnsson E; Jacobsen EI; Kalaitzakis E
    J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.